Clinical trial
Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
NCT00481013 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00481013 |
|---|---|
| Title | Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy |
| Official title | Prospective Controlled Trial of Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy (VALIANTSMA) Study |
| Acronym | VALIANTSMA |
| Lead sponsor | University of Utah, Other |
| Collaborators | Families of Spinal Muscular Atrophy Abbott Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Spinal Muscular Atrophy |
| Intervention type | Drug |
| Interventions | Valproic Acid (VPA), Placebo |
| Enrollment | 33 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Nov 1, 2010 |
| First posted | Jun 1, 2007 |
| Last update posted | Dec 6, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: